Skip to main content
Top
Published in: Abdominal Radiology 8/2019

01-08-2019 | Liposarcoma | Classics in Abdominal Radiology

Phantom (invisible) organ sign

Authors: Mohd Ilyas, Tariq A. Gojwari, Musaib Ahmad Dar, Akshit Kumar, Savia Gupta

Published in: Abdominal Radiology | Issue 8/2019

Login to get access

Excerpt

The “phantom organ sign” refers to the obscuration of a small organ when a large mass arising from it renders the organ invisible (Figs. 1 and 2). The sign can be seen, for example, in lesions arising from the adrenal gland: pheochromocytoma, large adenoma, and adrenocortical carcinoma [1].
Literature
1.
go back to reference Shabaan AM, Rezvani M, Tubay M, Elsayes KM, Woodward PJ, Menias CO (2016) Fat-containing retroperitoneal lesions: imaging characteristics, localization, and differential diagnosis. Radiographics, 36(3);710-734CrossRef Shabaan AM, Rezvani M, Tubay M, Elsayes KM, Woodward PJ, Menias CO (2016) Fat-containing retroperitoneal lesions: imaging characteristics, localization, and differential diagnosis. Radiographics, 36(3);710-734CrossRef
2.
go back to reference Nishino M, Hayakawa K, Minami M, Yamamoto A, Ueda H, Takasu K (2003) Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics, 23(1);45-57CrossRefPubMed Nishino M, Hayakawa K, Minami M, Yamamoto A, Ueda H, Takasu K (2003) Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics, 23(1);45-57CrossRefPubMed
Metadata
Title
Phantom (invisible) organ sign
Authors
Mohd Ilyas
Tariq A. Gojwari
Musaib Ahmad Dar
Akshit Kumar
Savia Gupta
Publication date
01-08-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02035-x

Other articles of this Issue 8/2019

Abdominal Radiology 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.